Cancer Nanotechnology最新文献

Correction: Cancer Nanotechnology (2023) 14:78 https://doi.org/10.1186/s12645-023-00230-6

In this article, the author name Tung-Ho Wu was incorrectly written as Dung-Ho Wu. The affiliation of the author is given in this correction.

The original article has been corrected.

Authors and Affiliations

1. Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung, 80708, Taiwan

   Huei-Jen Chen, Yi-An Cheng, Bo-Cheng Huang & Tian-Lu Cheng

2. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

   Huei-Jen Chen, Yu-Tung Chen, Chia-Ching Li, Shih-Ting Hong & Steve R. Rofer

3. Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan

   Bo-Cheng Huang, I.-Ju Chen, Kai-Wen Ho, Chiao-Yun Chen, Jaw-Yuan Wang & Tian-Lu Cheng

4. Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

   Tian-Lu Cheng

5. Department of Medical Imaging, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

   Chiao-Yun Chen

6. School of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

   Chiao-Yun Chen

7. Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

   Fang-Ming Chen

8. Department of Surgery, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan

   Fang-Ming Chen

9. Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

   Fang-Ming Chen

10. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan

    Steve R. Rofer

11. Department of Cardiovascular Surgeon, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan

    Tung-Ho Wu

12. School of Medicine, I-Shou University, Kaohsiung, Taiwan

    I.-Ju Chen

1. Huei-Jen ChenView author publications

   You can also search for this author in PubMed Google Scholar

2. Yi-An ChengView author publications

   You can also search for this author in PubMed Google Scholar

3. Yu-Tung ChenView author publications

   You can also search for this author in PubMed Google Scholar

4. Chia-Ching LiView author publications

   You can also search for this author in PubMed Google Scholar

5. Bo-Cheng HuangView author publications

   You can also search for this author in PubMed Google Scholar

6. Shih-Ting HongView author publications

   You can also search for this author in P

Retraction: Cancer Nanotechnology (2023) 14:71 https://doi.org/10.1186/s12645-023-00220-8

The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding overlapping images in the presented data. Specifically:

Multiple images in Fig. 8a appear highly similar to those in Fig. 17 in Naseer et al. (2023), representing different groups.

Multiple images in Fig. 8b appear highly similar to those in Fig. 18 in Naseer et al. (2023), representing different groups.

• Fig. 8a D1 appears highly similar to Fig. 8b D3.

• Fig. 8a E1 and E2 appear to overlap with different magnification.

• Fig. 9a A5 insert (low magnification image) appears highly similar to that in B5.

• Fig. 9a A9 and b D7 appear to overlap with different contrast.

• Fig. 9a A10, A12 and B10 appear to overlap.

• Fig. 9a B1 and b C1, C3 appear to overlap with different magnification.

• Fig. 9a B3 and b C2, D2 appear to overlap with different magnification and contrast.

• Fig. 9a B4 and b D4 appear to overlap.

• Fig. 9a B10 and B11 appear to overlap.

Additionally, the rat body weight data presented in Fig. 5a (~ 160 g at week 1) appear to be contrary to the description in the Methods (200–250 g).

The Editors-in-Chief therefore no longer have confidence in the presented data.

None of the authors have responded to any correspondence from the editor or publisher about this retraction notice.

• Naseer F, Kousar K, Abduh MS et al (2023) Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation. Cancer Nanotechnol 14:65. https://doi.org/10.1186/s12645-023-00218-2

  Article CAS Google Scholar

Download references

Authors and Affiliations

1. Industrial Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan

   Kousain Kousar, Faiza Naseer & Tahir Ahmad

2. Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan

   Faiza Naseer

3. Immune Responses in Different Diseases Research Group, Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdul-Aziz University, 21589, Jeddah, Saudi Arabia

   Maisa S. Abduh

4. Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia

   Maisa S. Abduh

<

Retraction Note: Cancer Nanotechnology (2023) 14:65 https://doi.org/10.1186/s12645-023-00218-2

The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding some of the images presented in the figures, specifically:

• Fig. 6 appears highly similar to Fig. 10 of Naseer et al. (2023)

• Fig. 6 Pure VC 12 h 90 ug/ml and VC-loaded TCs-HA 24 h 50 ug/ml images appear highly similar

• Fig. 17 A5 and Fig. 18 D5 images appear to overlap (flipped and with different magnification)

• Fig. 18 C6 and D6 appear to overlap (with different magnification)

• Several panels in Figs. 17 and 18 appear highly similar to those in Fig. 8 of Kousar et al. (2023)

The authors have been unable to provide the underlying raw data upon request. The Editors-in-Chief therefore no longer have confidence in the presented data.

None of the authors have responded to any correspondence from the editor or publisher about this retraction notice.

• Naseer F, Ahmad T, Kousar K, Kakar S, Gul R, Anjum S, Shareef U (2023) Formulation for the targeted delivery of a vaccine strain of oncolytic measles virus (OMV) in hyaluronic acid coated thiolated chitosan as a green nanoformulation for the treatment of prostate cancer: a viro-immunotherapeutic approach. Int J Nanomed 18:185–205. https://doi.org/10.2147/IJN.S386560

  Article CAS Google Scholar

• Kousar K, Naseer F, Abduh MS et al (2023) Green synthesis of oncolytic Newcastle disease virus-loaded thiolated chitosan nanoformulation for CD44 targeted delivery and sustained release of virus in cervical cancer xenografts. Cancer Nano 14:71. https://doi.org/10.1186/s12645-023-00220-8

  Article CAS Google Scholar

Download references

Authors and Affiliations

1. Industrial Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan

   Faiza Naseer, Kousain Kousar & Tahir Ahmad

2. Shifa College of Pharmaceutical Sciences, Shifa Tameer e Millat University, Islamabad, Pakistan

   Faiza Naseer

3. Immune Responses in Different Diseases Research Group, Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdul-Aziz University, 21589, Jeddah, Saudi Arabia

   Maisa S. Abduh

4. Department of Biology, University of Hail, Hail, Saudi Arabia

   Sadia Anjum

1. Faiza NaseerView author publications

   You can also search for this author in PubMed Google Sch